Budgeting
In 2018, total U.S. medical and health R&D investment was $194.2 billion. Of that, industry invested $129.5 billion, almost 67% of the total.
Insurers got repeal of the Cadillac tax, HIT and an extension of silver loading in year-end spending package.
Most patients showed willingness to use apps and online scheduling systems, but they were a lower priority than quality interactions.
After a slower growth rate in 2017, 2018 saw growth rates about equal to those of 2016, driven in part by the reinstatement of a fee on insurers.
Decreased labor expenses also contributed to the strong financial performance for the month, though non-labor expenses increased.
Legislative proposals could reduce bad debt, but would likely introduce additional complexity to billing processes.
The sophisticated techniques used in cognitive computing are the next frontier for AI in healthcare, and the results could be transformative.
The findings refute assertions that a reduction in drug spending would endanger access to life-saving drugs.
Lower supply spending doesn't have to translate to lower-quality care, an important consideration as providers look to tighten up their supply chains.
Real estate is increasingly becoming an avenue for providers to increase their revenue and footprint in the community.